+1 347 708 0418
ALK Positive Lung Cancer Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global ALK Positive Lung Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Crizotinib
Alectinib
Ceritinib
Brigatinib
Other
Segment by Application
Hospital
Clinics
Other
By Company
F. Hoffmann-La Roche
Pfizer
Novartis
TP Therapeutics
Bristol-Myers Squibb
Eli Lilly and Company
Takeda
Beacon Pharma
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global ALK Positive Lung Cancer Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Crizotinib
1.2.3 Alectinib
1.2.4 Ceritinib
1.2.5 Brigatinib
1.2.6 Other
1.3 Market by Application
1.3.1 Global ALK Positive Lung Cancer Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global ALK Positive Lung Cancer Treatment Market Perspective (2017-2028)
2.2 ALK Positive Lung Cancer Treatment Growth Trends by Region
2.2.1 ALK Positive Lung Cancer Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 ALK Positive Lung Cancer Treatment Historic Market Size by Region (2017-2022)
2.2.3 ALK Positive Lung Cancer Treatment Forecasted Market Size by Region (2023-2028)
2.3 ALK Positive Lung Cancer Treatment Market Dynamics
2.3.1 ALK Positive Lung Cancer Treatment Industry Trends
2.3.2 ALK Positive Lung Cancer Treatment Market Drivers
2.3.3 ALK Positive Lung Cancer Treatment Market Challenges
2.3.4 ALK Positive Lung Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top ALK Positive Lung Cancer Treatment Players by Revenue
3.1.1 Global Top ALK Positive Lung Cancer Treatment Players by Revenue (2017-2022)
3.1.2 Global ALK Positive Lung Cancer Treatment Revenue Market Share by Players (2017-2022)
3.2 Global ALK Positive Lung Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by ALK Positive Lung Cancer Treatment Revenue
3.4 Global ALK Positive Lung Cancer Treatment Market Concentration Ratio
3.4.1 Global ALK Positive Lung Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by ALK Positive Lung Cancer Treatment Revenue in 2021
3.5 ALK Positive Lung Cancer Treatment Key Players Head office and Area Served
3.6 Key Players ALK Positive Lung Cancer Treatment Product Solution and Service
3.7 Date of Enter into ALK Positive Lung Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 ALK Positive Lung Cancer Treatment Breakdown Data by Type
4.1 Global ALK Positive Lung Cancer Treatment Historic Market Size by Type (2017-2022)
4.2 Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Type (2023-2028)
5 ALK Positive Lung Cancer Treatment Breakdown Data by Application
5.1 Global ALK Positive Lung Cancer Treatment Historic Market Size by Application (2017-2022)
5.2 Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America ALK Positive Lung Cancer Treatment Market Size (2017-2028)
6.2 North America ALK Positive Lung Cancer Treatment Market Size by Type
6.2.1 North America ALK Positive Lung Cancer Treatment Market Size by Type (2017-2022)
6.2.2 North America ALK Positive Lung Cancer Treatment Market Size by Type (2023-2028)
6.2.3 North America ALK Positive Lung Cancer Treatment Market Share by Type (2017-2028)
6.3 North America ALK Positive Lung Cancer Treatment Market Size by Application
6.3.1 North America ALK Positive Lung Cancer Treatment Market Size by Application (2017-2022)
6.3.2 North America ALK Positive Lung Cancer Treatment Market Size by Application (2023-2028)
6.3.3 North America ALK Positive Lung Cancer Treatment Market Share by Application (2017-2028)
6.4 North America ALK Positive Lung Cancer Treatment Market Size by Country
6.4.1 North America ALK Positive Lung Cancer Treatment Market Size by Country (2017-2022)
6.4.2 North America ALK Positive Lung Cancer Treatment Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe ALK Positive Lung Cancer Treatment Market Size (2017-2028)
7.2 Europe ALK Positive Lung Cancer Treatment Market Size by Type
7.2.1 Europe ALK Positive Lung Cancer Treatment Market Size by Type (2017-2022)
7.2.2 Europe ALK Positive Lung Cancer Treatment Market Size by Type (2023-2028)
7.2.3 Europe ALK Positive Lung Cancer Treatment Market Share by Type (2017-2028)
7.3 Europe ALK Positive Lung Cancer Treatment Market Size by Application
7.3.1 Europe ALK Positive Lung Cancer Treatment Market Size by Application (2017-2022)
7.3.2 Europe ALK Positive Lung Cancer Treatment Market Size by Application (2023-2028)
7.3.3 Europe ALK Positive Lung Cancer Treatment Market Share by Application (2017-2028)
7.4 Europe ALK Positive Lung Cancer Treatment Market Size by Country
7.4.1 Europe ALK Positive Lung Cancer Treatment Market Size by Country (2017-2022)
7.4.2 Europe ALK Positive Lung Cancer Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size (2017-2028)
8.2 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Type
8.2.1 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific ALK Positive Lung Cancer Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Application
8.3.1 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific ALK Positive Lung Cancer Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Region
8.4.1 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America ALK Positive Lung Cancer Treatment Market Size (2017-2028)
9.2 Latin America ALK Positive Lung Cancer Treatment Market Size by Type
9.2.1 Latin America ALK Positive Lung Cancer Treatment Market Size by Type (2017-2022)
9.2.2 Latin America ALK Positive Lung Cancer Treatment Market Size by Type (2023-2028)
9.2.3 Latin America ALK Positive Lung Cancer Treatment Market Share by Type (2017-2028)
9.3 Latin America ALK Positive Lung Cancer Treatment Market Size by Application
9.3.1 Latin America ALK Positive Lung Cancer Treatment Market Size by Application (2017-2022)
9.3.2 Latin America ALK Positive Lung Cancer Treatment Market Size by Application (2023-2028)
9.3.3 Latin America ALK Positive Lung Cancer Treatment Market Share by Application (2017-2028)
9.4 Latin America ALK Positive Lung Cancer Treatment Market Size by Country
9.4.1 Latin America ALK Positive Lung Cancer Treatment Market Size by Country (2017-2022)
9.4.2 Latin America ALK Positive Lung Cancer Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size (2017-2028)
10.2 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Type
10.2.1 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa ALK Positive Lung Cancer Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Application
10.3.1 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa ALK Positive Lung Cancer Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Country
10.4.1 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Details
11.1.2 F. Hoffmann-La Roche Business Overview
11.1.3 F. Hoffmann-La Roche ALK Positive Lung Cancer Treatment Introduction
11.1.4 F. Hoffmann-La Roche Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022)
11.1.5 F. Hoffmann-La Roche Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer ALK Positive Lung Cancer Treatment Introduction
11.2.4 Pfizer Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022)
11.2.5 Pfizer Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis ALK Positive Lung Cancer Treatment Introduction
11.3.4 Novartis Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022)
11.3.5 Novartis Recent Developments
11.4 TP Therapeutics
11.4.1 TP Therapeutics Company Details
11.4.2 TP Therapeutics Business Overview
11.4.3 TP Therapeutics ALK Positive Lung Cancer Treatment Introduction
11.4.4 TP Therapeutics Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022)
11.4.5 TP Therapeutics Recent Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb ALK Positive Lung Cancer Treatment Introduction
11.5.4 Bristol-Myers Squibb Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022)
11.5.5 Bristol-Myers Squibb Recent Developments
11.6 Eli Lilly and Company
11.6.1 Eli Lilly and Company Company Details
11.6.2 Eli Lilly and Company Business Overview
11.6.3 Eli Lilly and Company ALK Positive Lung Cancer Treatment Introduction
11.6.4 Eli Lilly and Company Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022)
11.6.5 Eli Lilly and Company Recent Developments
11.7 Takeda
11.7.1 Takeda Company Details
11.7.2 Takeda Business Overview
11.7.3 Takeda ALK Positive Lung Cancer Treatment Introduction
11.7.4 Takeda Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022)
11.7.5 Takeda Recent Developments
11.8 Beacon Pharma
11.8.1 Beacon Pharma Company Details
11.8.2 Beacon Pharma Business Overview
11.8.3 Beacon Pharma ALK Positive Lung Cancer Treatment Introduction
11.8.4 Beacon Pharma Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022)
11.8.5 Beacon Pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global ALK Positive Lung Cancer Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Crizotinib
Table 3. Key Players of Alectinib
Table 4. Key Players of Ceritinib
Table 5. Key Players of Brigatinib
Table 6. Key Players of Other
Table 7. Global ALK Positive Lung Cancer Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global ALK Positive Lung Cancer Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global ALK Positive Lung Cancer Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global ALK Positive Lung Cancer Treatment Market Share by Region (2017-2022)
Table 11. Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global ALK Positive Lung Cancer Treatment Market Share by Region (2023-2028)
Table 13. ALK Positive Lung Cancer Treatment Market Trends
Table 14. ALK Positive Lung Cancer Treatment Market Drivers
Table 15. ALK Positive Lung Cancer Treatment Market Challenges
Table 16. ALK Positive Lung Cancer Treatment Market Restraints
Table 17. Global ALK Positive Lung Cancer Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global ALK Positive Lung Cancer Treatment Revenue Share by Players (2017-2022)
Table 19. Global Top ALK Positive Lung Cancer Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ALK Positive Lung Cancer Treatment as of 2021)
Table 20. Ranking of Global Top ALK Positive Lung Cancer Treatment Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by ALK Positive Lung Cancer Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players ALK Positive Lung Cancer Treatment Product Solution and Service
Table 24. Date of Enter into ALK Positive Lung Cancer Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global ALK Positive Lung Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global ALK Positive Lung Cancer Treatment Revenue Market Share by Type (2017-2022)
Table 28. Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global ALK Positive Lung Cancer Treatment Revenue Market Share by Type (2023-2028)
Table 30. Global ALK Positive Lung Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global ALK Positive Lung Cancer Treatment Revenue Share by Application (2017-2022)
Table 32. Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global ALK Positive Lung Cancer Treatment Revenue Share by Application (2023-2028)
Table 34. North America ALK Positive Lung Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America ALK Positive Lung Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America ALK Positive Lung Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America ALK Positive Lung Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America ALK Positive Lung Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America ALK Positive Lung Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe ALK Positive Lung Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe ALK Positive Lung Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe ALK Positive Lung Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe ALK Positive Lung Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe ALK Positive Lung Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe ALK Positive Lung Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific ALK Positive Lung Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific ALK Positive Lung Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific ALK Positive Lung Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific ALK Positive Lung Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific ALK Positive Lung Cancer Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific ALK Positive Lung Cancer Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America ALK Positive Lung Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America ALK Positive Lung Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America ALK Positive Lung Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America ALK Positive Lung Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America ALK Positive Lung Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America ALK Positive Lung Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa ALK Positive Lung Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa ALK Positive Lung Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa ALK Positive Lung Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa ALK Positive Lung Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa ALK Positive Lung Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa ALK Positive Lung Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 64. F. Hoffmann-La Roche Company Details
Table 65. F. Hoffmann-La Roche Business Overview
Table 66. F. Hoffmann-La Roche ALK Positive Lung Cancer Treatment Product
Table 67. F. Hoffmann-La Roche Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022) & (US$ Million)
Table 68. F. Hoffmann-La Roche Recent Developments
Table 69. Pfizer Company Details
Table 70. Pfizer Business Overview
Table 71. Pfizer ALK Positive Lung Cancer Treatment Product
Table 72. Pfizer Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022) & (US$ Million)
Table 73. Pfizer Recent Developments
Table 74. Novartis Company Details
Table 75. Novartis Business Overview
Table 76. Novartis ALK Positive Lung Cancer Treatment Product
Table 77. Novartis Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022) & (US$ Million)
Table 78. Novartis Recent Developments
Table 79. TP Therapeutics Company Details
Table 80. TP Therapeutics Business Overview
Table 81. TP Therapeutics ALK Positive Lung Cancer Treatment Product
Table 82. TP Therapeutics Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022) & (US$ Million)
Table 83. TP Therapeutics Recent Developments
Table 84. Bristol-Myers Squibb Company Details
Table 85. Bristol-Myers Squibb Business Overview
Table 86. Bristol-Myers Squibb ALK Positive Lung Cancer Treatment Product
Table 87. Bristol-Myers Squibb Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022) & (US$ Million)
Table 88. Bristol-Myers Squibb Recent Developments
Table 89. Eli Lilly and Company Company Details
Table 90. Eli Lilly and Company Business Overview
Table 91. Eli Lilly and Company ALK Positive Lung Cancer Treatment Product
Table 92. Eli Lilly and Company Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022) & (US$ Million)
Table 93. Eli Lilly and Company Recent Developments
Table 94. Takeda Company Details
Table 95. Takeda Business Overview
Table 96. Takeda ALK Positive Lung Cancer Treatment Product
Table 97. Takeda Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022) & (US$ Million)
Table 98. Takeda Recent Developments
Table 99. Beacon Pharma Company Details
Table 100. Beacon Pharma Business Overview
Table 101. Beacon Pharma ALK Positive Lung Cancer Treatment Product
Table 102. Beacon Pharma Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022) & (US$ Million)
Table 103. Beacon Pharma Recent Developments
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global ALK Positive Lung Cancer Treatment Market Share by Type: 2021 VS 2028
Figure 2. Crizotinib Features
Figure 3. Alectinib Features
Figure 4. Ceritinib Features
Figure 5. Brigatinib Features
Figure 6. Other Features
Figure 7. Global ALK Positive Lung Cancer Treatment Market Share by Application: 2021 VS 2028
Figure 8. Hospital Case Studies
Figure 9. Clinics Case Studies
Figure 10. Other Case Studies
Figure 11. ALK Positive Lung Cancer Treatment Report Years Considered
Figure 12. Global ALK Positive Lung Cancer Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global ALK Positive Lung Cancer Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global ALK Positive Lung Cancer Treatment Market Share by Region: 2021 VS 2028
Figure 15. Global ALK Positive Lung Cancer Treatment Market Share by Players in 2021
Figure 16. Global Top ALK Positive Lung Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ALK Positive Lung Cancer Treatment as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by ALK Positive Lung Cancer Treatment Revenue in 2021
Figure 18. North America ALK Positive Lung Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America ALK Positive Lung Cancer Treatment Market Size Market Share by Type (2017-2028)
Figure 20. North America ALK Positive Lung Cancer Treatment Market Size Market Share by Application (2017-2028)
Figure 21. North America ALK Positive Lung Cancer Treatment Market Size Share by Country (2017-2028)
Figure 22. United States ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe ALK Positive Lung Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe ALK Positive Lung Cancer Treatment Market Size Market Share by Type (2017-2028)
Figure 26. Europe ALK Positive Lung Cancer Treatment Market Size Market Share by Application (2017-2028)
Figure 27. Europe ALK Positive Lung Cancer Treatment Market Size Share by Country (2017-2028)
Figure 28. Germany ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific ALK Positive Lung Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific ALK Positive Lung Cancer Treatment Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific ALK Positive Lung Cancer Treatment Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific ALK Positive Lung Cancer Treatment Market Size Share by Region (2017-2028)
Figure 38. China ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America ALK Positive Lung Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America ALK Positive Lung Cancer Treatment Market Size Market Share by Type (2017-2028)
Figure 46. Latin America ALK Positive Lung Cancer Treatment Market Size Market Share by Application (2017-2028)
Figure 47. Latin America ALK Positive Lung Cancer Treatment Market Size Share by Country (2017-2028)
Figure 48. Mexico ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa ALK Positive Lung Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa ALK Positive Lung Cancer Treatment Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa ALK Positive Lung Cancer Treatment Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa ALK Positive Lung Cancer Treatment Market Size Share by Country (2017-2028)
Figure 54. Turkey ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. F. Hoffmann-La Roche Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2017-2022)
Figure 58. Pfizer Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2017-2022)
Figure 59. Novartis Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2017-2022)
Figure 60. TP Therapeutics Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2017-2022)
Figure 61. Bristol-Myers Squibb Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2017-2022)
Figure 62. Eli Lilly and Company Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2017-2022)
Figure 63. Takeda Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2017-2022)
Figure 64. Beacon Pharma Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Buy
